Historical Valuation
Adicet Bio Inc (ACET) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.26. The fair price of Adicet Bio Inc (ACET) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：8.11
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Adicet Bio Inc (ACET) has a current Price-to-Book (P/B) ratio of 0.46. Compared to its 3-year average P/B ratio of 0.55 , the current P/B ratio is approximately -15.06% higher. Relative to its 5-year average P/B ratio of 1.07, the current P/B ratio is about -56.62% higher. Adicet Bio Inc (ACET) has a Forward Free Cash Flow (FCF) yield of approximately -112.59%. Compared to its 3-year average FCF yield of -102.17%, the current FCF yield is approximately 10.20% lower. Relative to its 5-year average FCF yield of -66.12% , the current FCF yield is about 70.28% lower.
P/B
Median3y
0.55
Median5y
1.07
FCF Yield
Median3y
-102.17
Median5y
-66.12
Competitors Valuation Multiple
AI Analysis for ACET
The average P/S ratio for ACET competitors is 1329.24, providing a benchmark for relative valuation. Adicet Bio Inc Corp (ACET.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ACET
1Y
3Y
5Y
Market capitalization of ACET increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ACET in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ACET currently overvalued or undervalued?
Adicet Bio Inc (ACET) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.26. The fair price of Adicet Bio Inc (ACET) is between to according to relative valuation methord.
What is Adicet Bio Inc (ACET) fair value?
ACET's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Adicet Bio Inc (ACET) is between to according to relative valuation methord.
How does ACET's valuation metrics compare to the industry average?
The average P/S ratio for ACET's competitors is 1329.24, providing a benchmark for relative valuation. Adicet Bio Inc Corp (ACET) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Adicet Bio Inc (ACET) as of Jan 09 2026?
As of Jan 09 2026, Adicet Bio Inc (ACET) has a P/B ratio of 0.46. This indicates that the market values ACET at 0.46 times its book value.
What is the current FCF Yield for Adicet Bio Inc (ACET) as of Jan 09 2026?
As of Jan 09 2026, Adicet Bio Inc (ACET) has a FCF Yield of -112.59%. This means that for every dollar of Adicet Bio Inc’s market capitalization, the company generates -112.59 cents in free cash flow.
What is the current Forward P/E ratio for Adicet Bio Inc (ACET) as of Jan 09 2026?
As of Jan 09 2026, Adicet Bio Inc (ACET) has a Forward P/E ratio of -0.72. This means the market is willing to pay $-0.72 for every dollar of Adicet Bio Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Adicet Bio Inc (ACET) as of Jan 09 2026?
As of Jan 09 2026, Adicet Bio Inc (ACET) has a Forward P/S ratio of 0.00. This means the market is valuing ACET at $0.00 for every dollar of expected revenue over the next 12 months.